David Rodman Malcom Insider Trading Activity
David Rodman Malcom has been net-selling over the last 12 months with 0 purchases and 33 sales across 1 company.
MLYS is the most-traded position with 33 trades. The largest single transaction was a sale of MLYS for $4.8M on Jan 5, 2026.
Performance Scorecard
Forward stock performance after each transaction by David Rodman Malcom. Buy returns measure price movement after open-market purchases; sell-avoided measures the loss avoided after open-market sales. Success rate counts trades where the insider's direction was right.
| PERIOD | AVG BUY RETURN | AVG SELL AVOIDED | SUCCESS RATE | TRADES |
|---|---|---|---|---|
| 30 days | — | -0.2% | 74% | 35 |
| 90 days | — | -11.4% | 81% | 31 |
| 120 days | — | -13.0% | 70% | 27 |
Performance based on stock price movement after each transaction date. Past results do not predict future returns. Not financial advice.
Price & Trades
Pro: Trade MarkersMLYS · Mineralys Therapeutics, Inc.
🔒 Subscribe to see trade entries
Pro members see exactly when David Rodman Malcom bought and sold MLYS.
Upgrade to ProRecent Trades
| DATE | TICKER | TYPE | SHARES | PRICE | VALUE | Δ OWNED | ROLE | FILING |
|---|---|---|---|---|---|---|---|---|
May 18, 2026 | MLYS | Sell | 417 | $27.55 | $11K | −0.7% | Chief Medical Officer | |
May 13, 2026 | MLYS | Sell | 14,056 | $28.58 | $402K | −18.1% | Chief Medical Officer | |
May 12, 2026 | MLYS | Sell | 6,348 | $29.36 | $186K | −8.3% | Chief Medical Officer | |
May 11, 2026 | MLYS | Sell | 2,171 | $29.71 | $65K | −3.0% | Chief Medical Officer | |
Apr 17, 2026 | MLYS | Sell | 416 | $31.33 | $13K | −0.6% | Chief Medical Officer | |
Apr 15, 2026 | MLYS | Sell | 6,348 | $27.66 | $176K | −8.3% | Chief Medical Officer | |
Apr 13, 2026 | MLYS | Sell | 14,058 | $26.54 | $373K | −15.6% | Chief Medical Officer | |
Apr 9, 2026 | MLYS | Sell | 2,170 | $27.38 | $59K | −2.8% | Chief Medical Officer | |
Mar 17, 2026 | MLYS | Sell | 417 | $25.65 | $11K | −0.5% | Chief Medical Officer | |
Mar 13, 2026 | MLYS | Sell | 10,726 | $25.91 | $278K | −11.9% | Chief Medical Officer | |
Mar 13, 2026 | MLYS | Sell | 3,079 | $27.37 | $84K | −3.9% | Chief Medical Officer | |
Mar 13, 2026 | MLYS | Sell | 253 | $27.82 | $7K | −0.3% | Chief Medical Officer | |
Mar 12, 2026 | MLYS | Sell | 6,348 | $27.37 | $174K | −7.1% | Chief Medical Officer | |
Mar 9, 2026 | MLYS | Sell | 2,171 | $26.84 | $58K | −2.6% | Chief Medical Officer | |
Feb 17, 2026 | MLYS | Sell | 417 | $27.59 | $12K | −0.9% | Chief Medical Officer | |
Feb 13, 2026 | MLYS | Sell | 3,541 | $27.33 | $97K | −6.6% | Chief Medical Officer | |
Feb 13, 2026 | MLYS | Sell | 4,166 | $27.33 | $114K | −7.6% | Chief Medical Officer | |
Feb 13, 2026 | MLYS | Sell | 6,348 | $27.58 | $175K | −12.6% | Chief Medical Officer | |
Feb 12, 2026 | MLYS | Sell | 5,828 | $28.94 | $169K | −10.3% | Chief Medical Officer | |
Feb 12, 2026 | MLYS | Sell | 521 | $29.64 | $15K | −1.0% | Chief Medical Officer | |
Feb 9, 2026 | MLYS | Sell | 2,171 | $30.21 | $66K | −4.1% | Chief Medical Officer | |
Jan 20, 2026 | MLYS | Sell | 416 | $32.10 | $13K | −0.8% | Chief Medical Officer | |
Jan 14, 2026 | MLYS | Sell | 11,367 | $32.61 | $371K | −18.4% | Chief Medical Officer | |
Jan 13, 2026 | MLYS | Sell | 7,709 | $32.75 | $252K | −11.1% | Chief Medical Officer | |
Jan 12, 2026 | MLYS | Sell | 6,348 | $32.32 | $205K | −9.3% | Chief Medical Officer | |
Jan 9, 2026 | MLYS | Sell | 2,170 | $33.27 | $72K | −3.4% | Chief Medical Officer | |
Jan 5, 2026 | MLYS | Sell | 139,245 | $34.83 | $4.8M | −54.7% | Chief Medical Officer | |
Jan 5, 2026 | MLYS | Sell | 53,470 | $35.53 | $1.9M | −46.4% | Chief Medical Officer | |
Jan 2, 2026 | MLYS | Sell | 70,037 | $35.87 | $2.5M | −50.3% | Chief Medical Officer | |
Oct 15, 2025 | MLYS | Sell | 10,369 | $43.01 | $446K | −12.7% | Chief Medical Officer | |
Sep 15, 2025 | MLYS | Sell | 9,302 | $35.90 | $334K | −10.0% | Chief Medical Officer | |
Sep 15, 2025 | MLYS | Sell | 2,065 | $36.47 | $75K | −2.5% | Chief Medical Officer | |
Aug 13, 2025 | MLYS | Sell | 11,365 | $12.93 | $147K | −10.9% | Chief Medical Officer | |
Jul 14, 2025 | MLYS | Sell | 11,366 | $14.59 | $166K | −10.4% | Chief Medical Officer | |
Jun 13, 2025 | MLYS | Sell | 11,366 | $14.60 | $166K | −10.1% | Chief Medical Officer |
Top Companies Traded
| TICKER | COMPANY | TRADES | TOTAL VOLUME |
|---|---|---|---|
| MLYS | Mineralys Therapeutics, Inc. | 35 | $14.1M |
Other insiders at Mineralys Therapeutics, Inc.
5 other tracked filers at MLYS.